SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-036390
Filing Date
2020-08-05
Accepted
2020-08-05 06:12:14
Documents
68
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cnst-10q_20200630.htm   iXBRL 10-Q 2790851
2 EX-10.1 cnst-ex101_158.htm EX-10.1 68937
3 EX-10.2 cnst-ex102_160.htm EX-10.2 57186
4 EX-31.1 cnst-ex311_7.htm EX-31.1 9605
5 EX-31.2 cnst-ex312_8.htm EX-31.2 9578
6 EX-32.1 cnst-ex321_9.htm EX-32.1 5672
7 EX-32.2 cnst-ex322_6.htm EX-32.2 5752
  Complete submission text file 0001564590-20-036390.txt   8615951

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA cnst-20200630.xsd EX-101.SCH 42694
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cnst-20200630_cal.xml EX-101.CAL 41530
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnst-20200630_def.xml EX-101.DEF 128627
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnst-20200630_lab.xml EX-101.LAB 339304
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnst-20200630_pre.xml EX-101.PRE 260381
13 EXTRACTED XBRL INSTANCE DOCUMENT cnst-10q_20200630_htm.xml XML 1678114
Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Filer) CIK: 0001434418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38584 | Film No.: 201075500
SIC: 2834 Pharmaceutical Preparations